Aptevo Therapeutics (APVO) Misses Q3 EPS by 48c
Tweet
Share
E-mailGet Alerts APVO Hot Sheet
Join SI Premium – FREE
Aptevo Therapeutics (NASDAQ: APVO) reported Q3 EPS of ($0.48).
For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays sees global expansion intact, warns against market complacency
- Lake Street Starts Alpha & Omega Semiconductor (AOSL) at Buy
- Travere Therapeutics (TVTX) PT Raised to $65 at Guggenheim
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
